0001140361-23-026845.txt : 20230526 0001140361-23-026845.hdr.sgml : 20230526 20230526090025 ACCESSION NUMBER: 0001140361-23-026845 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230523 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20230526 DATE AS OF CHANGE: 20230526 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 23963266 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 8-K 1 brhc20053532_8k.htm 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) May 26, 2023 (May 23, 2023)

Merck & Co., Inc.
(Exact name of registrant as specified in its charter)

New Jersey
1-6571
22-1918501
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S Employer Identification No.)
 
126 East Lincoln Avenue
Rahway
New Jersey
07065
(Address of principal executive offices)
(Zip Code)
 
(Registrant’s telephone number, including area code) (908) 740-4000

Not Applicable
(Former name, former address and former fiscal year, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company  ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
 
Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock ($0.50 par value)
MRK
New York Stock Exchange
0.500% Notes due 2024
MRK 24
New York Stock Exchange
1.875% Notes due 2026
MRK/26
New York Stock Exchange
2.500% Notes due 2034
MRK/34
New York Stock Exchange
1.375% Notes due 2036
MRK 36A
New York Stock Exchange

Item 5.07.
Submission of Matters to a Vote of Security Holders.


(a)
The Annual Meeting of Shareholders of Merck & Co., Inc. (the "Company") was held on May 23, 2023.

(b)
Shareholders voted on the matters set forth below:

1.
The following nominees were elected to the Company’s Board of Directors to hold office until the Company’s next Annual Meeting of Shareholders and received the number of votes set forth opposite their names:

Names
Votes For
Votes Against
Abstentions
Broker
Non-Votes
Percent of Votes
Cast For
Douglas M. Baker, Jr.
1,831,441,722
33,955,060
4,441,078
303,475,463
98.17%
Mary Ellen Coe
1,831,352,905
33,590,197
4,894,758
303,475,463
98.19%
Pamela J. Craig
1,825,716,789
39,919,623
4,201,448
303,475,463
97.86%
Robert M. Davis
1,701,209,534
157,428,174
11,200,152
303,475,463
91.52%
Thomas H. Glocer
1,727,334,643
137,793,210
4,710,007
303,475,463
92.61%
Risa J. Lavizzo-Mourey, M.D.
1,817,190,279
48,426,594
4,220,987
303,475,463
97.40%
Stephen L. Mayo, Ph.D.
1,853,609,739
11,176,418
5,051,703
303,475,463
99.40%
Paul B. Rothman, M.D.
1,852,736,770
12,058,989
5,042,101
303,475,463
99.35%
Patricia F. Russo
1,606,388,270
258,957,288
4,492,302
303,475,463
86.11%
Christine E. Seidman, M.D.
1,852,721,080
12,244,549
4,872,231
303,475,463
99.34%
Inge G. Thulin
1,809,508,166
55,312,366
5,017,328
303,475,463
97.03%
Kathy J. Warden
1,823,144,498
41,748,693
4,944,669
303,475,463
97.76%
Peter C. Wendell
1,783,743,993
81,345,153
4,748,714
303,475,463
95.63%

2.
Non-binding advisory vote to approve the compensation of our named executive officers:

 
1,697,425,819
  
votes FOR
       
 
161,718,633
  
votes AGAINST
       
or an affirmative vote of 91.30% of the total votes cast.
       
 
10,693,408
  
shares abstained from voting.
       
 
303,475,463
  
broker non votes.

3.
Non-binding advisory vote to approve the frequency of future votes to approve the compensation of our named executive officers:

 
1,835,407,619
  
votes ONE YEAR
       
 
3,907,809
  
votes TWO YEARS
       
 
24,899,809
  
votes THREE YEARS
       
or an affirmative vote of 99.98% of the total votes cast.
       
 
5,622,623
  
shares abstained from voting.
       
 
303,475,463
  
broker non votes.

4.
Ratification of the appointment of the Company’s independent registered public accounting firm for 2023:

 
2,043,709,187
  
votes FOR
       
 
124,208,470
  
votes AGAINST
       
or an affirmative vote of 94.27% of the total votes cast.
       
 
5,395,666
  
shares abstained from voting.

5.
Shareholder proposal regarding business operations in China:

 
69,754,041
  
votes FOR
       
 
1,748,779,515
  
votes AGAINST
       
or an affirmative vote of 3.83% of the total votes cast.
       
 
51,304,304
  
shares abstained from voting.
       
 
303,475,463
  
broker non votes.

6.
Shareholder proposal regarding access to COVID-19 products:

 
574,496,614
  
votes FOR
       
 
1,264,355,494
  
votes AGAINST
       
or an affirmative vote of 31.24% of the total votes cast.
       
 
30,985,752
  
shares abstained from voting.
       
 
303,475,463
  
broker non votes.

7.
Shareholder proposal regarding indirect political spending:

 
134,569,780
  
votes FOR
       
 
1,706,198,205
  
votes AGAINST
       
or an affirmative vote of 7.31% of the total votes cast.
       
 
29,069,875
  
shares abstained from voting.
       
 
303,475,463
  
broker non votes.

8.
Shareholder proposal regarding patents and access:

 
571,866,383
  
votes FOR
       
 
1,266,959,770
  
votes AGAINST
       
or an affirmative vote of 31.09% of the total votes cast.
       
 
31,011,707
  
shares abstained from voting.
       
 
303,475,463
  
broker non votes.

9.
Shareholder proposal regarding a congruency report of partnerships with globalist organizations:

 
21,684,751
  
votes FOR
       
 
1,822,435,800
  
votes AGAINST
       
or an affirmative vote of 1.17% of the total votes cast.
       
 
25,717,309
  
shares abstained from voting.
       
 
303,475,463
  
broker non votes.

10.
Shareholder proposal regarding an independent board chairman:

 
604,053,803
  
votes FOR
       
 
1,258,675,075
  
votes AGAINST
       
or an affirmative vote of 32.42% of the total votes cast.
       
 
7,108,982
  
shares abstained from voting.
       
 
303,475,463
  
broker non votes.

A majority of the votes cast was required for all ten proposals to be approved.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Merck & Co., Inc.


Date: May 26, 2023
By:
/s/ Kelly E. W. Grez


Kelly E. W. Grez


Corporate Secretary


EX-101.SCH 2 mrk-20230523.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 mrk-20230523_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 4 mrk-20230523_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Class of Stock [Domain] Common Stock [Member] Class of Stock [Axis] Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Entity Listings [Table] Entity Listings [Line Items] Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name 0.500% Notes due 2024 [Member] 2.500% Notes due 2034 [Member] 1.875% Notes due 2026 [Member] 1.375% Notes due 2036 [Member] EX-101.PRE 5 mrk-20230523_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information
May 23, 2023
Entity Listings [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 23, 2023
Entity File Number 1-6571
Entity Registrant Name Merck & Co., Inc.
Entity Central Index Key 0000310158
Entity Incorporation, State or Country Code NJ
Entity Tax Identification Number 22-1918501
Entity Address, Address Line One 126 East Lincoln Avenue
Entity Address, City or Town Rahway
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 07065
City Area Code 908
Local Phone Number 740-4000
Entity Emerging Growth Company false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Common Stock [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security Common Stock ($0.50 par value)
Trading Symbol MRK
Security Exchange Name NYSE
0.500% Notes due 2024 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 0.500% Notes due 2024
Trading Symbol MRK 24
Security Exchange Name NYSE
1.875% Notes due 2026 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 1.875% Notes due 2026
Trading Symbol MRK/26
Security Exchange Name NYSE
2.500% Notes due 2034 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 2.500% Notes due 2034
Trading Symbol MRK/34
Security Exchange Name NYSE
1.375% Notes due 2036 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 1.375% Notes due 2036
Trading Symbol MRK 36A
Security Exchange Name NYSE
XML 7 brhc20053532_8k_htm.xml IDEA: XBRL DOCUMENT 0000310158 2023-05-23 2023-05-23 0000310158 mrk:Zero500NotesDue2024Member 2023-05-23 2023-05-23 0000310158 us-gaap:CommonStockMember 2023-05-23 2023-05-23 0000310158 mrk:One875NotesDue2026Member 2023-05-23 2023-05-23 0000310158 mrk:One375NotesDue2036Member 2023-05-23 2023-05-23 0000310158 mrk:Two500NotesDue2034Member 2023-05-23 2023-05-23 false 0000310158 8-K 2023-05-23 Merck & Co., Inc. NJ 1-6571 22-1918501 126 East Lincoln Avenue Rahway NJ 07065 908 740-4000 false false false false false Common Stock ($0.50 par value) MRK NYSE 0.500% Notes due 2024 MRK 24 NYSE 1.875% Notes due 2026 MRK/26 NYSE 2.500% Notes due 2034 MRK/34 NYSE 1.375% Notes due 2036 MRK 36A NYSE EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 6 22 1 false 5 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://merck.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports brhc20053532_8k.htm mrk-20230523.xsd mrk-20230523_def.xml mrk-20230523_lab.xml mrk-20230523_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "brhc20053532_8k.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 34 }, "contextCount": 6, "dts": { "definitionLink": { "local": [ "mrk-20230523_def.xml" ] }, "inline": { "local": [ "brhc20053532_8k.htm" ] }, "labelLink": { "local": [ "mrk-20230523_lab.xml" ] }, "presentationLink": { "local": [ "mrk-20230523_pre.xml" ] }, "schema": { "local": [ "mrk-20230523.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 38, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 4, "memberStandard": 1, "nsprefix": "mrk", "nsuri": "http://merck.com/20230523", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc20053532_8k.htm", "contextRef": "c20230523to20230523", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://merck.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc20053532_8k.htm", "contextRef": "c20230523to20230523", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 5, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityListingsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Listings [Line Items]" } } }, "localname": "EntityListingsLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityListingsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container for exchange listing information for an entity", "label": "Entity Listings [Table]" } } }, "localname": "EntityListingsTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "trueItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "mrk_One375NotesDue2036Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "1.375% Notes due 2036 [Member]" } } }, "localname": "One375NotesDue2036Member", "nsuri": "http://merck.com/20230523", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mrk_One875NotesDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "1.875% Notes due 2026 [Member]" } } }, "localname": "One875NotesDue2026Member", "nsuri": "http://merck.com/20230523", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mrk_Two500NotesDue2034Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "2.500% Notes due 2034 [Member]" } } }, "localname": "Two500NotesDue2034Member", "nsuri": "http://merck.com/20230523", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mrk_Zero500NotesDue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "0.500% Notes due 2024 [Member]" } } }, "localname": "Zero500NotesDue2024Member", "nsuri": "http://merck.com/20230523", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://merck.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001140361-23-026845-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-23-026845-xbrl.zip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